X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7584) 7584
Book Chapter (63) 63
Magazine Article (59) 59
Dissertation (19) 19
Publication (19) 19
Book / eBook (7) 7
Conference Proceeding (3) 3
Newsletter (2) 2
Newspaper Article (2) 2
Reference (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5036) 5036
vitamin k - antagonists & inhibitors (2692) 2692
warfarin (2504) 2504
male (2281) 2281
female (2222) 2222
anticoagulants (2130) 2130
anticoagulants - therapeutic use (1839) 1839
aged (1682) 1682
vitamin k (1604) 1604
anticoagulants - adverse effects (1469) 1469
atrial fibrillation (1455) 1455
middle aged (1396) 1396
anticoagulants - administration & dosage (1309) 1309
hematology (1178) 1178
risk factors (1136) 1136
administration, oral (1123) 1123
stroke (1075) 1075
peripheral vascular disease (964) 964
dabigatran (957) 957
cardiac & cardiovascular systems (904) 904
thromboembolism (895) 895
vitamin k antagonists (871) 871
rivaroxaban (868) 868
animals (853) 853
atrial fibrillation - drug therapy (853) 853
hemorrhage - chemically induced (846) 846
anticoagulation (844) 844
aged, 80 and over (832) 832
international normalized ratio (810) 810
adult (808) 808
risk (791) 791
management (763) 763
therapy (714) 714
venous thromboembolism (707) 707
treatment outcome (706) 706
atrial-fibrillation (703) 703
bleeding (675) 675
vitamin-k antagonists (662) 662
pharmacology & pharmacy (652) 652
prevention (649) 649
medicine, general & internal (642) 642
patients (626) 626
stroke - prevention & control (612) 612
atrial fibrillation - complications (593) 593
thrombosis (573) 573
cardiac arrhythmia (516) 516
hemorrhage (514) 514
warfarin - adverse effects (513) 513
apixaban (510) 510
warfarin - therapeutic use (506) 506
vitamin k antagonist (498) 498
safety (496) 496
analysis (494) 494
oral anticoagulants (473) 473
warfarin - administration & dosage (462) 462
care and treatment (461) 461
abridged index medicus (460) 460
retrospective studies (453) 453
medicine & public health (449) 449
thromboembolism - prevention & control (436) 436
fibrillation (432) 432
stroke prevention (430) 430
time factors (420) 420
mortality (418) 418
antagonists (414) 414
anticoagulants - pharmacology (411) 411
blood coagulation - drug effects (400) 400
antithrombotic therapy (395) 395
oral anticoagulation (384) 384
drug therapy (374) 374
prospective studies (370) 370
rats (366) 366
cardiology (364) 364
vitamin k - pharmacology (353) 353
vitamin-k (352) 352
risk assessment (347) 347
dose-response relationship, drug (343) 343
vitamin k - therapeutic use (342) 342
stroke - etiology (341) 341
health aspects (340) 340
research (337) 337
prothrombin (332) 332
direct oral anticoagulants (328) 328
aspirin (327) 327
thrombin (317) 317
clinical trials (316) 316
molecular-weight heparin (314) 314
heparin (311) 311
venous thromboembolism - drug therapy (310) 310
internal medicine (305) 305
surgery (304) 304
dosage and administration (298) 298
vitamins (293) 293
prothrombin complex concentrate (291) 291
efficacy (286) 286
coagulation (284) 284
fibrinolytic agents - therapeutic use (284) 284
heparin - therapeutic use (282) 282
metaanalysis (278) 278
follow-up studies (277) 277
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6593) 6593
French (614) 614
German (366) 366
Spanish (107) 107
Japanese (68) 68
Russian (62) 62
Italian (43) 43
Portuguese (34) 34
Danish (24) 24
Hungarian (21) 21
Polish (20) 20
Dutch (14) 14
Korean (12) 12
Norwegian (8) 8
Romanian (6) 6
Swedish (6) 6
Chinese (5) 5
Czech (4) 4
Turkish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Serbian (1) 1
Slovenian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation (New York, N.Y.), ISSN 0009-7322, 09/2013, Volume 128, Issue 11, pp. 1234 - 1243
BACKGROUND—Patients experiencing major bleeding while taking vitamin K antagonists require rapid vitamin K antagonist reversal... 
CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | GUIDELINES | RISK | vitamin K antagonist | prothrombin complex concentrates | PREVIOUSLY UNTREATED PATIENTS | INTRACRANIAL HEMORRHAGE | THERAPY | TRANSFUSION | REVERSING WARFARIN ANTICOAGULATION | anticoagulants | PERIPHERAL VASCULAR DISEASE | plasma | FRESH-FROZEN PLASMA | hemorrhage | TRAUMA | Single-Blind Method | Plasma | Prospective Studies | Thromboembolism - chemically induced | Factor IX - therapeutic use | Humans | Middle Aged | Male | Factor IX - adverse effects | Hemorrhage - prevention & control | Vitamin K - antagonists & inhibitors | Thromboembolism - prevention & control | Aged, 80 and over | Adult | Factor X - therapeutic use | Female | Factor X - adverse effects | Factor VII - adverse effects | Factor VII - therapeutic use | Emergencies | Anticoagulants - therapeutic use | Treatment Outcome | Prothrombin - therapeutic use | Anticoagulants - adverse effects | Prothrombin - adverse effects | Hemostatics - adverse effects | International Normalized Ratio | Hemorrhage - drug therapy | Blood Coagulation Factors - adverse effects | Anticoagulants - pharmacology | Blood Coagulation Factors - therapeutic use | Aged | Hemorrhage - chemically induced | Hemostatics - therapeutic use | Drug Combinations | Antidotes - therapeutic use | Antagonists (Biochemistry) | Usage | Care and treatment | Blood coagulation factors | Health aspects | Hemorrhage
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2018, Volume 319, Issue 5, pp. 463 - 473
Journal Article
Journal Article
Journal Article